| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.11 | 0.7 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |